S L Adile1, G A Peyman, M D Greve
1LSU Eye Center, Louisiana State University Medical Center School of Medicine, New Orleans 70112-2234.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Perfluoroperhydrophenanthrene (Vitreon) did not significantly alter chronic intraocular pressure (IOP) abnormalities when used as a retinal manipulator or tamponade. Its safety profile for IOP management is comparable to C3F8, SF6 gases, and silicone oil.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: